Exclusive: NICE to routinely review drugs' budget impact for NHS England

By Sharon Brennan2017-05-11T12:00:00

The National Institute for Health and Care Excellence has been asked to routinely assess the financial impact of specialised commissioning treatments for NHS England, a document seen by HSJ reveals.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here